According to Stoke Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.95. In 2022 the company made an earnings per share (EPS) of -ยฃ2.01 a decrease over its 2021 EPS that were of -ยฃ1.80.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ2.10 | 4.7% |
2022 | -ยฃ2.01 | 11.59% |
2021 | -ยฃ1.80 | 49.36% |
2020 | -ยฃ1.21 | -32.14% |
2019 | -ยฃ1.78 | 331.68% |
2018 | -ยฃ0.41 |